As shown in Figure 3A, WT+WD/CCl4 mice exhibited increased LPS serum levels compared to control mice, whereas the intestinal activation of LXRα in mice exposed to WD/CCl4 treatment resulted in lower LPS serum levels than in WT+WD/CCl4 mice. The gene discussed is NR1H3; the disease is Wilson disease.